The next era of clinic software is structured, reviewed, and measurable.
Peptodyssey is a bioscience software company built around a simple idea: clinic workflows are stronger when intake, rationale, and follow-up are documented consistently.
Peptide and GLP-1 programs are growing, but many clinics still rely on scattered intake notes and inconsistent follow-up records. That makes it harder to explain what was reviewed, what will be monitored, and why the next visit matters.
We help boutique peptide clinics use structured screening and biomarker tracking workflows to document care context more deliberately and keep patients engaged with a clear follow-up process.
Peptodyssey is software for the clinics doing the care. Providers make the clinical decisions; we give them the structure and the record around them.
Authored as product material, not medical advice
Florida Man Bioscience
Peptodyssey content is written from the company’s product and regulatory-workflow perspective for clinic operators. It is not patient education and not prescribing guidance.
Required before care use — named reviewer pending
Any clinical workflow deployed in a pilot must be reviewed with licensed clinical leadership and governed by the clinic’s HIPAA, CDS, and medical-review process. We have not yet engaged a named medical reviewer for these public pages; once one is engaged, that reviewer’s name and credential will be published here. We do not claim a credential we do not have.
See it on your own patient panel
If you run a peptide or GLP-1 clinic and want to measure outcomes and retain more patients, we’d like to show you how Peptodyssey fits your workflow.